Il4i1 binds to tmprss13 and competes with sars-cov-2 spike

HIGHLIGHTS

• who: Ju00e9rô from the National Cancer Institute (INCA), Brazil Uludag University, Turkey have published the Article: IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike, in the Journal: (JOURNAL)
• what: The authors show the existence of a new candidate receptor for the immunosuppressive enzyme IL4I1 and identify this protein as the serine protease TMPRSS13. The authors show that TMPRSS13 is expressed by various immune cell types, with the percentage of positive cells greatly varying between donors, suggesting that the effect of IL4I1 could vary between individuals. The authors show that macrophages can . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.